FMR LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 21 filers reported holding UROGEN PHARMA LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
FMR LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$68,915
+1223.8%
4,919
+877.9%
0.00%
Q2 2023$5,206
-37.9%
503
-44.6%
0.00%
Q1 2023$8,390
+108.3%
908
+100.0%
0.00%
Q4 2022$4,027
+0.7%
4540.0%0.00%
Q3 2022$4,0000.0%454
-15.9%
0.00%
Q2 2022$4,000
+33.3%
540
+82.4%
0.00%
Q1 2022$3,000
-99.6%
296
-99.4%
0.00%
Q2 2021$727,000
-21.6%
47,6030.0%0.00%
Q1 2021$927,000
+8.0%
47,6030.0%0.00%
Q4 2020$858,000
-25.5%
47,603
-20.3%
0.00%
Q3 2020$1,152,000
-80.6%
59,703
-73.8%
0.00%
-100.0%
Q2 2020$5,942,000
+5.9%
227,503
-27.7%
0.00%0.0%
Q1 2020$5,613,000
-46.5%
314,6030.0%0.00%0.0%
Q4 2019$10,498,000
-25.1%
314,603
-46.5%
0.00%
-50.0%
Q3 2019$14,017,000
-33.7%
588,2030.0%0.00%0.0%
Q2 2019$21,140,000
-2.7%
588,2030.0%0.00%
-33.3%
Q1 2019$21,728,000
-9.2%
588,203
+5.8%
0.00%0.0%
Q4 2018$23,941,000
-8.8%
556,0030.0%0.00%0.0%
Q3 2018$26,260,000
-25.3%
556,003
-21.3%
0.00%
-25.0%
Q2 2018$35,161,000
-18.1%
706,614
-18.3%
0.00%
-20.0%
Q1 2018$42,953,000
+67.3%
864,427
+25.3%
0.01%
+66.7%
Q4 2017$25,669,000
+5.9%
689,830
-10.3%
0.00%0.0%
Q3 2017$24,246,000
+74.5%
769,2300.0%0.00%
+50.0%
Q2 2017$13,892,000769,2300.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders